Newest Issue is Out. Get your exclusive copy today.

Subscribe for Free

Crucial Decision-making in Drug Development for COVID-19

A Decade of Reinforcing Business Integrity

WORKING TOGETHER, APART

DIGITAL SOLUTIONS IN DRUG DEVELOPMENT

PATIENT-CENTRIC CLINICAL TRIALS

Double-blinding Capsules for Clinical Trials

THE IMPORTANCE OF PRINCIPAL INVESTIGATOR TRAINING

INTEGRATED CONTINUOUS BIOMANUFACTURING

Human Vaccine Candidates Discovery and Development on Non-Animal Systems

THE DIGITALISATION OF THE CRYSTALLISATION PROCESS

ARTIFICIAL INTELLIGENCE IN PHARMACY PRACTICE

Get instant access to latest e-book

LATEST NEWSRead more...

28

Sep 2020

AVROBIO Receives Orphan Drug Designation from the European Medicines Agency for AVR-RD-02, an Investigational Gene Therapy for Gaucher Disease

AVROBIO Inc a leading clinicalstage gene therapy company with a mission to free people from a lifetime of genetic disease announced that the European Commission EC has granted orphan drug designation for AVRRD the companys investigational gene therapy for the treatment of Gaucher disease

26

Sep 2020

Vivet Therapeutics and Pfizer Inc. Sign Agreement to Manufacture Investigational Gene Therapy Product Developed by Vivet for Wilson's Disease

Vivet Therapeutics Vivet a privately held gene therapy biotechnology company dedicated to developing treatments for severe inherited liver diseases and Pfizer Inc announced that have signed a manufacturing agreement under which Pfizer will supply the necessary material for a phase clinical trial t...

25

Sep 2020

AbCellera and IGM Biosciences Announce Multi-Year Antibody Discovery Collaboration

AbCellera and IGM Biosciences Inc announced today that they have entered into a multiyear multitarget strategic research collaboration and license agreement to facilitate the discovery and development of novel IgM antibodies

25

Sep 2020

Lumen Bioscience Awarded Federal Grant to Rapidly Develop Nanobody-based Covid-19 Therapeutic

Lumen Bioscience a clinicalstage biopharmaceutical company developing biologic drugs for highly prevalent diseases and the US Army Medical Research and Development Command USAMRDC operating through the Medical Technology Enterprise Consortium MTEC announced an agreement to develop a rapid scalable a...

press releasesRead more...

28

Sep 2020

60 years of Packaging Excellence - Syntegon’s Schiedam site celebrates anniversary and long heritage

Syntegon Technologys Schiedam site is celebrating over half a century of market presence In October the companys Dutch site turns Today a marketleading provider of horizontal flow wrappers infeed and distribution systems the current Syntegon Packaging Technology BV took up business as Tevopharm

28

Sep 2020

Etihad Cargo Reinforces Pharmaceutical Shipment Expertise With PharmaLife Launch

Etihad Cargo the cargo and logistics arm of Etihad Aviation Group has reinforced its pharmaceutical logistics expertise with the launch of PharmaLife a specialised pharma and healthcare product which replaces the carriers TempCheck productb

28

Sep 2020

FDA Grants IND Approval for Phase II Clinical Trial Using Stemedica's itMSC Therapy for COVID-19 Patients

Stemedica Cell Technologies Inc has received US Food and Drug Administration FDA Investigational New Drug IND approval for A Phase II MultiCenter Randomized DoubleBlind PlaceboControlled Study to Assess the Safety Tolerability and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells...

26

Sep 2020

FDA Approves Nucala as the First and Only Biologic Treatment for Hypereosinophilic Syndrome (HES)

GlaxoSmithKline plc announced the US Food and Drug Administration FDA has approved Nucala mepolizumab for the treatment of adult and pediatric patients aged years and older with Hypereosinophilic Syndrome HES for six months without an identifiable nonhematologic secondary cause

EventsRead more...

28 - 29

Sep 2020

World Pharmaceutical Sciences & Drug Delivery

28 - 30

Sep 2020

Brain and Neurological Disorders

Iris Scientific Group
Rome

28 - 29

Sep 2020

Biotechnology & Bioengineering

28 - 29

Sep 2020

Pharmaceutics & Pharmaceutical Technology

Stockholm

29 - 30

Sep 2020

World Congress on Advanced Genetics

Tokyo

29 - 01

Sep 2020

Pharma CI USA

Pharma CI Conference
Virtual

Sartorius - New Entris® II Laboratory Balances

KNOWLEDGE BANK

Interviews

Life Sciences - Clinical, TNT Asia

Director
Clinical trials have very detailed and precise processes and the logistical elements of these processes are critical Recent revisions to the pharmaceutical industrys regulatory laws as well as improved patent laws in countries such as Japan China and...

Articles

Standard Operating Protocol (SOP) for The Clinical Diagnosis of Novel Coronavirus(COVID-19) Infection

The outbreak of a novel Coronavirus COVID in has led to an unexpected alteration in human lives and economic activities There is a global increase in the number of COVID infected people every day and the ability of this virus to spread rapidly has been a major concern

Research Insights

Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection

Antiretroviral therapy ART for HIV infection is lifelong Stopping therapy typically leads to the reignition of infection and progressive disease In a major breakthrough recent studies have shown that early initiation of ART can lead to sustained posttreatment control of viremia

Case Studies

Pediatrician’s Cough And Cold Medication Prescription For Hypothetical Cases: A Cross-Sectional Multi-Centric Case Study

Abstract Cough and cold is the most common cause for hospital visits and so is the use of cough and cold medication CCM A cough and cold medication has been considered to contain a single ingredient SI or multiple ingredients MI like promethazine PRZ chlorpheniramine CPM pseudoephedrine PS phenylephrine PE diphenhydramine DPH dextromethor

Techno Trends

FDA Grants Breakthrough Therapy Designation to Fennec PEDMARK™

The US Food and Drug Administration FDA awarded breakthrough therapy designation to Fennec Pharmaceuticals PEDMARK a unique formulation of sodium thiosulfate for prevention of cisplatinrelated ototoxicity in pediatric patients with standardrisk hepatoblastomaSRHB The Fast Track designation will facilitate development and accelerate the review of drugs to treat seri...

White Papers

Crippled by Cost? CMO Quo Vadis

Introduction The global CMO market is said to reach USD billion by Patent expiry of drugs stringent price regulations especially in Europe US to purchase drugs from pharma companies Government budget cuts for pharma RD these are the forces which are expected to reshape the future of pharma and the CMO industry At least manufacturing facilities owned by pharma com...

Advisory Board

Stella

Sanjoy Ray

Rustom

Phil

Neil J

Laurence

Kenneth I

Georg C

Frank A

Douglas

Christopher-

Alan S Louie

EDITORIAL SECTION

STRATEGY

Natural Intelligence

Despite the hype the routine use of AI in marketing in the life sciences is a long way away

RESEARCH DEVELOPMENT

OCULAR DRUG DELIVERY PERSPECTIVE

As per the estimation of a Forbes analysis around US billion is spent by large pharmaceutical companiesfor a single drug approval

CLINICAL TRIALS

CLINICAL TRIALS IN A PETRI DISH

Clinical trials include experiments and the related observations done in clinical settings as part of prospective biomedical research studies on human...

MANUFACTURING

EMERGING TECHNOLOGIES FOR PARTICLE ENGINEERING

The constant requirement for the targeted delivery of therapeutically active agents has been the key driver in particle engineering and processing wit...

Information Technology

The Cyber-Physical Security of Pharmaceutical Manufacturing Processes

The cyberphysical security is no longer an area that should be overlooked Unfortunately cyberphysical attacks of all kinds may cost companies a great...

EXPERT Talk

PHARMA LOGISTICS TRENDS

Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...

Crucial Decision-making in Drug Development for COVID-19

A Decade of Reinforcing Business Integrity

WORKING TOGETHER, APART

DIGITAL SOLUTIONS IN DRUG DEVELOPMENT

PATIENT-CENTRIC CLINICAL TRIALS

Double-blinding Capsules for Clinical Trials

THE IMPORTANCE OF PRINCIPAL INVESTIGATOR TRAINING

INTEGRATED CONTINUOUS BIOMANUFACTURING

Human Vaccine Candidates Discovery and Development on Non-Animal Systems

THE DIGITALISATION OF THE CRYSTALLISATION PROCESS

ARTIFICIAL INTELLIGENCE IN PHARMACY PRACTICE

Get instant access to latest e-book

LATEST NEWSRead more...

28

AVROBIO Receives Orphan Drug Designation from the European Medicines Agency for AVR-RD-02, an Investigational Gene Therapy for Gaucher Disease

26

Vivet Therapeutics and Pfizer Inc. Sign Agreement to Manufacture Investigational Gene Therapy Product Developed by Vivet for Wilson's Disease

25

AbCellera and IGM Biosciences Announce Multi-Year Antibody Discovery Collaboration

25

Lumen Bioscience Awarded Federal Grant to Rapidly Develop Nanobody-based Covid-19 Therapeutic

press releasesRead more...

28

60 years of Packaging Excellence - Syntegon’s Schiedam site celebrates anniversary and long heritage

28

Etihad Cargo Reinforces Pharmaceutical Shipment Expertise With PharmaLife Launch

28

FDA Grants IND Approval for Phase II Clinical Trial Using Stemedica's itMSC Therapy for COVID-19 Patients

26

FDA Approves Nucala as the First and Only Biologic Treatment for Hypereosinophilic Syndrome (HES)

EventsRead more...

28 - 29

World Pharmaceutical Sciences & Drug Delivery

28 - 30

Brain and Neurological Disorders

28 - 29

Biotechnology & Bioengineering

28 - 29

Pharmaceutics & Pharmaceutical Technology

29 - 30

World Congress on Advanced Genetics

29 - 01

Pharma CI USA

Advertisements

TOP ARTICLES

1

Luminescent Carbon Dots: An Emerging Nanomedicine to Treat Antibiotic Resistant Bacterial Infections

2

Electronic Counters for Bottle Filling

3

Bioscintigraphy: An Innovative Tool For Drug Product Development

4

Nano-based Drug Delivery System for Hacking Colon Cancer Cells

5

Prioritisation of Raw Materials in Healthcare Industry

KNOWLEDGE BANK

Life Sciences - Clinical, TNT Asia

Standard Operating Protocol (SOP) for The Clinical Diagnosis of Novel Coronavirus(COVID-19) Infection

Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection

Pediatrician’s Cough And Cold Medication Prescription For Hypothetical Cases: A Cross-Sectional Multi-Centric Case Study

FDA Grants Breakthrough Therapy Designation to Fennec PEDMARK™

Crippled by Cost? CMO Quo Vadis

Advisory Board

EDITORIAL SECTION

Natural Intelligence

OCULAR DRUG DELIVERY PERSPECTIVE

CLINICAL TRIALS IN A PETRI DISH

EMERGING TECHNOLOGIES FOR PARTICLE ENGINEERING

The Cyber-Physical Security of Pharmaceutical Manufacturing Processes

PHARMA LOGISTICS TRENDS